LAWYERS from Oxford firm Royds Withy King advised biotech company Oxford Genetics on a £7.5m investment to fund a new US office and boost research in the UK.

Jennifer Sampson and Tony Roberts from the corporate and commercial team worked with Oxford Genetics chief executive Ryan Cawood and his team on the terms of the agreement with an existing and new investor.

Mr Cawood said: “Working with Royds Withy King on this deal was great, they supported Oxford Genetics throughout and helped us negotiate this strategic investment that will allow us to significantly expand our operations.

“Having a lawyer who responded to emails at 6am in the morning of our closing was pretty reassuring.”